We evaluate the growth of tumor cell lines in four distinct experimental groups: the control group, the PUMA knockdown group, the control group treated with C75 (a FASN inhibitor, 35 μM), and the PUMA knockdown group treated with C75. This evidence concerns the gene FASN and neoplasm.